|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 122 out of 122 for Nlrp12

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.02s

Categories

Category: Publication
Type Details Score
Publication
First Author: Braun AD
Year: 2020
Journal: J Invest Dermatol
Title: Activated Hgf-Met Signaling Cooperates with Oncogenic BRAF to Drive Primary Cutaneous Melanomas and Angiotropic Lung Metastases in Mice.
Volume: 140
Issue: 7
Pages: 1410-1417.e2
Publication
First Author: Hölzel M
Year: 2016
Journal: Cancer Res
Title: A Preclinical Model of Malignant Peripheral Nerve Sheath Tumor-like Melanoma Is Characterized by Infiltrating Mast Cells.
Volume: 76
Issue: 2
Pages: 251-63
Publication  
First Author: Deken MA
Year: 2016
Journal: Int J Mol Sci
Title: Dermal Delivery of Constructs Encoding Cre Recombinase to Induce Skin Tumors in PtenLoxP/LoxP;BrafCA/+ Mice.
Volume: 17
Issue: 12
Publication
First Author: Sanchez-Laorden B
Year: 2014
Journal: Sci Signal
Title: BRAF inhibitors induce metastasis in RAS mutant or inhibitor-resistant melanoma cells by reactivating MEK and ERK signaling.
Volume: 7
Issue: 318
Pages: ra30
Publication
First Author: Rae J
Year: 2012
Journal: J Invest Dermatol
Title: (V600E)Braf::Tyr-CreERT2::K14-Kitl mice do not develop superficial spreading-like melanoma: keratinocyte Kit ligand is insufficient to "translocate" (V600E)Braf-driven melanoma to the epidermis.
Volume: 132
Issue: 2
Pages: 488-91
Publication
First Author: van Tuyn J
Year: 2017
Journal: J Invest Dermatol
Title: Oncogene-Expressing Senescent Melanocytes Up-Regulate MHC Class II, a Candidate Melanoma Suppressor Function.
Volume: 137
Issue: 10
Pages: 2197-2207
Publication
First Author: Boussouar A
Year: 2020
Journal: Cancer Res
Title: Netrin-1 and Its Receptor DCC Are Causally Implicated in Melanoma Progression.
Volume: 80
Issue: 4
Pages: 747-756
Publication
First Author: Galvani E
Year: 2020
Journal: Nat Commun
Title: Stroma remodeling and reduced cell division define durable response to PD-1 blockade in melanoma.
Volume: 11
Issue: 1
Pages: 853
Publication
First Author: Trucco LD
Year: 2019
Journal: Nat Med
Title: Ultraviolet radiation-induced DNA damage is prognostic for outcome in melanoma.
Volume: 25
Issue: 2
Pages: 221-224
Publication
First Author: Trucco LD
Year: 2021
Journal: J Invest Dermatol
Title: Map3k1 Loss Cooperates with BrafV600E to Drive Melanomagenesis.
Volume: 141
Issue: 1
Pages: 221-225.e6
Publication      
First Author: Aktary Z
Year: 2019
Journal: Pigment Cell Melanoma Res
Title: Sequencing two Tyr::CreERT2 transgenic mouse lines.
Publication
First Author: Karras P
Year: 2019
Journal: Cancer Cell
Title: p62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic Factors.
Volume: 35
Issue: 1
Pages: 46-63.e10
Publication
First Author: Li A
Year: 2011
Journal: Dev Cell
Title: Rac1 drives melanoblast organization during mouse development by orchestrating pseudopod- driven motility and cell-cycle progression.
Volume: 21
Issue: 4
Pages: 722-34
Publication
First Author: Li A
Year: 2012
Journal: J Invest Dermatol
Title: Activated mutant NRas(Q61K) drives aberrant melanocyte signaling, survival, and invasiveness via a Rac1-dependent mechanism.
Volume: 132
Issue: 11
Pages: 2610-21
Publication  
First Author: Dorard C
Year: 2017
Journal: Nat Commun
Title: RAF proteins exert both specific and compensatory functions during tumour progression of NRAS-driven melanoma.
Volume: 8
Pages: 15262
Publication
First Author: Yajima I
Year: 2013
Journal: PLoS One
Title: A subpopulation of smooth muscle cells, derived from melanocyte-competent precursors, prevents patent ductus arteriosus.
Volume: 8
Issue: 1
Pages: e53183
Publication
First Author: Le Coz M
Year: 2021
Journal: J Invest Dermatol
Title: Targeted Knockout of β-Catenin in Adult Melanocyte Stem Cells Using a Mouse Line, Dct::CreERT2, Results in Disrupted Stem Cell Renewal and Pigmentation Defects.
Volume: 141
Issue: 5
Pages: 1363-1366.e9
Publication
First Author: Smith MP
Year: 2014
Journal: Cancer Discov
Title: The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNFα.
Volume: 4
Issue: 10
Pages: 1214-1229
Publication
First Author: Hamm M
Year: 2021
Journal: Nat Commun
Title: BRN2 is a non-canonical melanoma tumor-suppressor.
Volume: 12
Issue: 1
Pages: 3707
Publication  
First Author: Kümper S
Year: 2016
Journal: Elife
Title: Rho-associated kinase (ROCK) function is essential for cell cycle progression, senescence and tumorigenesis.
Volume: 5
Pages: e12994
Publication  
First Author: Yao W
Year: 2022
Journal: JCI Insight
Title: Keratinocyte-derived cytokine TSLP promotes growth and metastasis of melanoma by regulating the tumor-associated immune microenvironment.
Volume: 7
Issue: 21
Publication
First Author: Gerhard DS
Year: 2004
Journal: Genome Res
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
Volume: 14
Issue: 10B
Pages: 2121-7